Editorial: COVID-19 vaccines are safe and effective in patients with inflammatory bowel disease-but many unanswered questions remain. Authors' reply.

Bhurwal, Abhishek; Mutneja, Hemant; Seril, Darren

Bhurwal, Abhishek; Mutneja, Hemant; Seril, Darren.

Bhurwal A; Division of Gastroenterology and Hepatology, Rutgers Robert Wood Johnson University Hospital, New Brunswick, New Jersey, USA.
Mutneja H; Division of Gastroenterology and Hepatology, John H Stroger Cook County Hospital, Chicago, Illinois, USA.
Seril D; Division of Gastroenterology and Hepatology, Rutgers Robert Wood Johnson University Hospital, New Brunswick, New Jersey, USA.

Aliment Pharmacol Ther ; 56(1): 164-165, 2022 07.

Article in English | MEDLINE | ID: covidwho-1886644

Subject(s)

COVID-19; Inflammatory Bowel Diseases; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Chronic Disease; Humans; Inflammatory Bowel Diseases/therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Experimental Studies Topics: Vaccines Limits: Humans Language: English Journal: Aliment Pharmacol Ther Journal subject: Pharmacology / Gastroenterology / Drug Therapy Year: 2022 Document Type: Article Affiliation country: Apt.16976

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google